ibandronic acid has been researched along with calcitriol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bauss, F; Friedler, RM; Malluche, HH; Monier-Faugere, MC | 1 |
| Schlosser, K; Scigalla, P | 1 |
| Duvos, C; Mayer, H; Scutt, A | 1 |
| Amrein, K; Dimai, HP; Dobnig, H; Fahrleitner-Pammer, A; Kniepeiss, D; Kornprat, P; Pieber, T; Tscheliessnigg, KH; Wagner, D | 1 |
| Åsberg, A; Bollerslev, J; Dolgos, S; Godang, K; Hartmann, A; Midtvedt, K; Olsen, IC; Pfeffer, P; Reisæter, AV; Sagedal, S; Smerud, KT; Ueland, T | 1 |
1 review(s) available for ibandronic acid and calcitriol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for ibandronic acid and calcitriol
| Article | Year |
|---|---|
Biochemical markers as surrogates in clinical trials in patients with metastatic bone disease and osteoporosis.
Topics: Absorptiometry, Photon; Administration, Oral; Adult; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Bone Resorption; Calcitriol; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ibandronic Acid; Injections, Intravenous; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Placebos; Procollagen | 1997 |
A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation.
Topics: Administration, Intravenous; Bone Density; Bone Density Conservation Agents; Bone Resorption; Calcitriol; Calcium, Dietary; Diphosphonates; Double-Blind Method; Female; Humans; Ibandronic Acid; Kidney Transplantation; Male; Maximum Tolerated Dose; Middle Aged; Osteoporosis; Vitamins | 2012 |
3 other study(ies) available for ibandronic acid and calcitriol
| Article | Year |
|---|---|
A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs.
Topics: Animals; Bone and Bones; Bone Resorption; Calcitriol; Diphosphonates; Dogs; Female; Ibandronic Acid; Models, Biological; Osteoporosis; Ovariectomy; Parathyroid Hormone | 1993 |
Individual and combined effects of calciotropic hormones and growth factors on mineral metabolism in embryonic chick tibiae.
Topics: Alkaline Phosphatase; Animals; Bone Resorption; Calcifediol; Calcitonin; Calcitriol; Calcium; Chick Embryo; Diphosphonates; Growth Substances; Ibandronic Acid; Insulin-Like Growth Factor I; Organ Culture Techniques; Parathyroid Hormone; Tibia | 1997 |
Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after LTX.
Topics: Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Calcitriol; Diphosphonates; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Ibandronic Acid; Liver Transplantation; Male; Middle Aged; Osteoporosis; Parathyroid Hormone; Risk | 2012 |